Medable Inc. a leading provider of innovative clinical trial technologies that provide data-driven and digitally enabled clinical trials, and Synexus, the leading global network of dedicated research sites, announced today the launch of Medable Telemedicine, a solution that enables site sponsors to conduct secure, HIPAA-compliant video consultations with clinical study participants.
About 35% of patients drop out of clinical trials due to lack of patient-centric mobile design. Medable Telemedicine has been developed and designed to overcome this hurdle of patient retention.
“We are excited to announce our telehealth service offering with our partner Synexus, as telehealth can help lower costs and improve efficiency in clinical trials. By leveraging health technology and digital resources to drive better, faster patient care, our gal is to expand access to clinical trials to individuals regardless of physical location,” said Dr. Michelle Longmire, CEO and co-founder at Medable.